Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Mukka Proteins Investor Presentation: Key Takeaways

Mukka Proteins reported strong Q1 FY27 results, driven by favorable fishmeal pricing and improved realizations as it transitions into an integrated animal protein and sustainability platform.

Guidance and delivery
Management target Revenue 107.0% FY30
Highlights
Revenue growth₹489.7 Cr vs ₹170.8 Cr YoY.
MarginsQ1 FY27 EBITDA margin at 9.9% vs 12.9% in Q4 FY26.
Order bookSecured integrated animal waste management contract from BBMP/BSWML.
Demand visibilityStrong domestic and export demand across 25+ countries.
Management confidenceHigh; citing multi-year growth driven by integration and expansion.

Growth

Revenue grew significantly to ₹489.7 Cr in Q1 FY27 from ₹170.8 Cr in Q1 FY26. EBITDA reached ₹48.6 Cr.

Outlook

Targeting over 2x revenue growth in ~4 years (₹3,000+ Cr by FY30). Upcoming Oman facility expanding production capacity.

Risks

Supply constraints in fishmeal expected globally by 2028; climate change (El Niño) impacting raw material availability.

Source

Investor Presentation filed with NSE, NSE: MUKKA. Summary written with AI assistance from the document.

Read the document ↗

Mukka Proteins Ltd: key numbers

Share price
₹27.40
Market cap
₹822.0 Cr
Revenue (annual)
₹1,449 Cr
Net profit (annual)
₹52.06 Cr
P/E (TTM)
11.9×Sector 29.0×
Promoter holding
73.33%+0.00% QoQ
FII holding
1.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mukka Proteins Ltd

All →
22:45 IST BSE
Management Change

Mukka Proteins Management Change

Mukka Proteins Limited announced the re-appointment of six directors to its board, including independent and executive members, each for a five-year term.

22:36 IST NSE
Annual General Meeting

Mukka Proteins Annual General Meeting

Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026. The meeting covered financial adoption, director re-appointments, and other routine business.

10:24 IST BSE
Capital Structure Change

Mukka Proteins Capital Structure Change

Mukka Proteins allot 2 Crore convertible warrants to 15 non-promoter investors at Rs. 23.50, raising Rs. 47 Crore. Warrants convert to one equity share in 18 months.

Value
₹47.00 Cr
17:31 IST BSE
Regulatory Approval

Mukka Proteins Regulatory Approval

Mukka Proteins received an 'EU - Inputs Attestation' from ECOCERT S.A.S. for its 'Eco Sphere Organic Fertilizer', validating its suitability for use in organic farming.

Execution
Valid from September 4, 2026, until March 31, 2028
17:23 IST NSE
Business Update

Mukka Proteins Business Update

Mukka Proteins received an EU-Inputs Attestation from ECOCERT S.A.S., France, for its Eco Sphere Organic Fertilizer. This confirms suitability for organic farming, enhancing product marketability.

16:40 IST BSE
Financial Results

Mukka Proteins Q1 FY27 Results: Net Profit ₹18.6 Cr, Up 1062.5% YoY

Mukka Proteins Ltd reported revenue from operations of ₹489.7 Cr (+186.7% YoY) and net profit of ₹18.6 Cr (+1062.5% YoY) for Q1 FY27.

Key figure
Net profit ₹18.6 Cr · +1062.5% YoY